Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMARIN CORP PLC\UKAMRN · Entity 5970 | Director | April 18, 2026 | April 21, 2026 |
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMARIN CORP PLC\UK
Report date April 18, 2026 · Filed April 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 836 |
Last balance in matching sequence
After 2026-04-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-04-18 · Exercise / conversion · Acquired 838 · Balance 1,239 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027. F3: Not applicable. Row 2 · 2026-04-18 · Tax withholding · Disposed 403 · Balance 836 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 838 |
Reported balance
After 2026-04-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-18 · Exercise / conversion · Acquired 838 · Balance 838 F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027. F3: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change.
F2: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027.
F3: Not applicable.
F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.
LEXICON PHARMACEUTICALS, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 126,122 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Exercise / conversion · Acquired 89,312 · Balance 126,122 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-03 · Exercise / conversion · Disposed 89,312 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 20:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000107 · form4.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 89,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000107 · form4.xml · nonDerivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 43,478 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001062822-26-000075 · form4.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,478 Underlying: Common Stock · 43,478 shares Expires 2036-05-01 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 35,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000075 · form4.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,714 Underlying: Common Stock · 35,714 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 18, 2026 Filed Apr 21, 2026 21:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 838 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-167113 · ownership.xml · derivative · entry 3 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838 Underlying: American Depositary Shares · 838 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · derivative.exercise_date: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| April 18, 2026 Filed Apr 21, 2026 21:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingAmerican Depositary Shares | 403 | $14.98 | $6,036.94 |
DisclosureSEC source: 0001193125-26-167113 · ownership.xml · nonDerivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 836 F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| April 18, 2026 Filed Apr 21, 2026 21:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionAmerican Depositary Shares | 838 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-167113 · ownership.xml · nonDerivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · kind: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F3 · price: Not applicable. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:24 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016476 · form4.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,312 Underlying: Common Stock · 89,312 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:24 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 103,806 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001127602-25-016476 · form4.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,806 Underlying: Common Stock · 103,806 shares Expires 2035-06-03 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2025 Filed May 13, 2025 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014145 · form4.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2025 Filed May 13, 2025 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 36,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014145 · form4.xml · nonDerivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2025 Filed Apr 23, 2025 01:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 838 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-056928 · ownership.xml · derivative · entry 3 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,676 Underlying: American Depositary Shares · 838 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · derivative.exercise_date: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an award that vests in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027 F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| April 18, 2025 Filed Apr 23, 2025 01:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingAmerican Depositary Shares | 437 | $9.11 | $3,981.07 |
DisclosureSEC source: 0000950170-25-056928 · ownership.xml · nonDerivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401 F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| April 18, 2025 Filed Apr 23, 2025 01:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionAmerican Depositary Shares | 838 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-056928 · ownership.xml · nonDerivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · kind: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an award that vests in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027 F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F3 · price: Not applicable F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:04 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015083 · form4.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:04 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015083 · form4.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 20:37 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 50,287 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046062 · ownership.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,287 Underlying: Ordinary Shares · 50,287 shares Expires not disclosed F3 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an award of 50,287 RSUs under the Plan and the Policy. These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 20:37 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 179,795 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0000950170-24-046062 · ownership.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,795 Underlying: Ordinary Shares · 179,795 shares Expires 2034-04-18 F1 · derivative.exercise_date: On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an option to purchase 179,795 Ordinary Shares under the Plan and the Policy. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the remaining balance vesting in equal quarterly installments over the subsequent two years on the first day of each April, July, October and January. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 12:14 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 96,515 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001127602-23-021546 · form4.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,515 Underlying: Common Stock · 96,515 shares Expires 2033-07-27 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| July 21, 2023 Filed Jul 22, 2023 01:04 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 55,804 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-033899 · ownership.xml · derivative · entry 4 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,804 Underlying: Ordinary Shares · 55,804 shares Expires not disclosed F4 · security: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F7 · derivative.exercise_date: On July 21, 2023, following the conclusion of the Issuer's annual general meeting of shareholders for 2023, the Reporting Person was granted an award of 55,804 RSUs under the Plan and the Policy. These RSUs vest in full upon the earlier of the one-year anniversary of the grant date and the annual general meeting of shareholders in such anniversary year. The RSUs are subject to deferred settlement upon the director's separation of service with the Issuer. F6 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 21, 2023 Filed Jul 22, 2023 01:04 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 94,866 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-033899 · ownership.xml · derivative · entry 3 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,866 Underlying: Ordinary Shares · 94,866 shares Expires not disclosed F4 · security: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_date: In connection with the Reporting Person's initial appointment to the Issuer's board of directors, on July 21, 2023 the Reporting Person was granted a one-time grant of 94,866 RSUs under the Plan and the Policy. These RSUs vest in equal annual installments over three years from the date of the Reporting Person's initial appointment to the Issuer's board of directors. The RSUs are subject to deferred settlement upon the director's separation of service with the Issuer. F6 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 21, 2023 Filed Jul 22, 2023 01:04 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 167,411 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0000950170-23-033899 · ownership.xml · derivative · entry 2 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,411 Underlying: Ordinary Shares · 167,411 shares Expires 2033-07-21 F3 · derivative.exercise_date: On July 21, 2023, following the conclusion of the Issuer's annual general meeting of shareholders for 2023, the Reporting Person was granted an option to purchase 167,411 Ordinary Shares under the Plan and the Policy. This option shall vest and become exercisable upon the earlier of the one-year anniversary of the grant date and the annual general meeting of shareholders in such anniversary year. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 21, 2023 Filed Jul 22, 2023 01:04 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 284,598 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0000950170-23-033899 · ownership.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,598 Underlying: Ordinary Shares · 284,598 shares Expires 2033-07-21 F1 · derivative.exercise_date: In connection with the Reporting Person's initial appointment to the Issuer's board of directors, on July 21, 2023 the Reporting Person was granted a one-time option to purchase 284,598 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan") and the Non-Employee Director Compensation Policy, as revised in May 2023 (the "Policy"). This option shall vest and become exercisable in equal annual installments over three years from the date of the Reporting Person's initial appointment to the Issuer's board of directors. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.